论文部分内容阅读
应用口服他巴唑（ＭＭＩ）后ＫＣｌＯ４释放试验方法，观察甲状腺机能亢进患者治疗后的甲状腺功能。结果表明，４５例受试者中３８例ＫＣｌＯ４释放率＜１０％（正常），７例ＫＣｌＯ４释放率＞１０％。４５例中的１７例同时做了甲状腺抑制试验，其结果与ＫＣｌＯ４释放试验有较好的符合率，说明该方法对判断甲亢治疗后的甲状腺功能有一定价值。
KClO4 release test was applied after oral Mabadazole (MMI) to observe thyroid function after treatment in patients with hyperthyroidism. The results showed that 38 of 45 subjects had KClO4 release rate <10% (normal) and 7 KClO4 release rate> 10%. Thirteen of the 45 patients underwent thyroid suppression test at the same time. The results were in good agreement with the KClO4 release test, indicating that this method is of value in judging thyroid function after hyperthyroidism treatment.